Ocriplasmin for foveal schisis in x-linked retinoschisis

Amar Patel, Lawrence S Morse

Research output: Contribution to journalArticle

  • 3 Citations

Abstract

Purpose: To report a case of foveal schisis in X-linked retinoschisis treated with ocriplasmin. Methods: Case report. Results: A 27-year-old man with X-linked retinoschisis was treated with a single intravitreal injection of ocriplasmin. After injection, a posterior vitreous detachment was induced and the macular schisis cavity resolved at 1 week. Central macular thickness on optical coherence tomography decreased from 731 mm to 185 mm, visual acuity remained unchanged, and there were no adverse events. However, the macular schisis cavity recurred at 1 month. Conclusion: This is the first reported case of using ocriplasmin to treat foveal schisis in X-linked retinoschisis. Although vitreomacular traction was relieved, the schisis cavity recurred shortly after initial closure.

LanguageEnglish (US)
Pages248-251
Number of pages4
JournalRetinal Cases and Brief Reports
Volume9
Issue number3
DOIs
StatePublished - Jun 6 2015

Fingerprint

Retinoschisis
Vitreous Detachment
Intravitreal Injections
Optical Coherence Tomography
Traction
Visual Acuity
Injections
microplasmin

Keywords

  • ocriplasmin
  • X-linked retinoschisis

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Ocriplasmin for foveal schisis in x-linked retinoschisis. / Patel, Amar; Morse, Lawrence S.

In: Retinal Cases and Brief Reports, Vol. 9, No. 3, 06.06.2015, p. 248-251.

Research output: Contribution to journalArticle

@article{d9fe768cad2942eab71bf024f15c5e37,
title = "Ocriplasmin for foveal schisis in x-linked retinoschisis",
abstract = "Purpose: To report a case of foveal schisis in X-linked retinoschisis treated with ocriplasmin. Methods: Case report. Results: A 27-year-old man with X-linked retinoschisis was treated with a single intravitreal injection of ocriplasmin. After injection, a posterior vitreous detachment was induced and the macular schisis cavity resolved at 1 week. Central macular thickness on optical coherence tomography decreased from 731 mm to 185 mm, visual acuity remained unchanged, and there were no adverse events. However, the macular schisis cavity recurred at 1 month. Conclusion: This is the first reported case of using ocriplasmin to treat foveal schisis in X-linked retinoschisis. Although vitreomacular traction was relieved, the schisis cavity recurred shortly after initial closure.",
keywords = "ocriplasmin, X-linked retinoschisis",
author = "Amar Patel and Morse, {Lawrence S}",
year = "2015",
month = "6",
day = "6",
doi = "10.1097/ICB.0000000000000151",
language = "English (US)",
volume = "9",
pages = "248--251",
journal = "Retinal Cases and Brief Reports",
issn = "1935-1089",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Ocriplasmin for foveal schisis in x-linked retinoschisis

AU - Patel, Amar

AU - Morse, Lawrence S

PY - 2015/6/6

Y1 - 2015/6/6

N2 - Purpose: To report a case of foveal schisis in X-linked retinoschisis treated with ocriplasmin. Methods: Case report. Results: A 27-year-old man with X-linked retinoschisis was treated with a single intravitreal injection of ocriplasmin. After injection, a posterior vitreous detachment was induced and the macular schisis cavity resolved at 1 week. Central macular thickness on optical coherence tomography decreased from 731 mm to 185 mm, visual acuity remained unchanged, and there were no adverse events. However, the macular schisis cavity recurred at 1 month. Conclusion: This is the first reported case of using ocriplasmin to treat foveal schisis in X-linked retinoschisis. Although vitreomacular traction was relieved, the schisis cavity recurred shortly after initial closure.

AB - Purpose: To report a case of foveal schisis in X-linked retinoschisis treated with ocriplasmin. Methods: Case report. Results: A 27-year-old man with X-linked retinoschisis was treated with a single intravitreal injection of ocriplasmin. After injection, a posterior vitreous detachment was induced and the macular schisis cavity resolved at 1 week. Central macular thickness on optical coherence tomography decreased from 731 mm to 185 mm, visual acuity remained unchanged, and there were no adverse events. However, the macular schisis cavity recurred at 1 month. Conclusion: This is the first reported case of using ocriplasmin to treat foveal schisis in X-linked retinoschisis. Although vitreomacular traction was relieved, the schisis cavity recurred shortly after initial closure.

KW - ocriplasmin

KW - X-linked retinoschisis

UR - http://www.scopus.com/inward/record.url?scp=84930441416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930441416&partnerID=8YFLogxK

U2 - 10.1097/ICB.0000000000000151

DO - 10.1097/ICB.0000000000000151

M3 - Article

VL - 9

SP - 248

EP - 251

JO - Retinal Cases and Brief Reports

T2 - Retinal Cases and Brief Reports

JF - Retinal Cases and Brief Reports

SN - 1935-1089

IS - 3

ER -